MINERVA SURGICAL INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch UTRS and buy or sell other stocks, ETFs, and their options commission-free!

About UTRS

Minerva Surgical, Inc. engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. It offers therapeutic devices for abnormal uterine bleeding treatment. 

CEO
Todd Usen
CEOTodd Usen
Employees
174
Employees174
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
2008
Founded2008
Employees
174
Employees174

UTRS Key Statistics

Market cap
35.51K
Market cap35.51K
Price-Earnings ratio
-4.26
Price-Earnings ratio-4.26
Dividend yield
Dividend yield
Average volume
839.84K
Average volume839.84K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.8835
52 Week high$0.8835
52 Week low
$0.1499
52 Week low$0.1499

Stock Snapshot

With a market cap of 35.51K, MINERVA SURGICAL INC(UTRS) trades at $0.00. The stock has a price-to-earnings ratio of -4.26.

MINERVA SURGICAL INC(UTRS) stock opened on 2026-01-24 at —. The price climbed to — and dipped to —.

The MINERVA SURGICAL INC(UTRS)'s current trading volume is 0, compared to an average daily volume of 839.84K.

In the last year, MINERVA SURGICAL INC(UTRS) shares hit a 52-week high of $0.88 and a 52-week low of $0.15.

In the last year, MINERVA SURGICAL INC(UTRS) shares hit a 52-week high of $0.88 and a 52-week low of $0.15.

People also own

Based on the portfolios of people who own UTRS. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.